Opium tincture 100 MG/ML Oral Solution — RxCUI 830196
RxNorm drug concept · Semantic clinical drug
RxCUI 830196
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI830196
Official nameOpium tincture 100 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asopium tincture 10 % Oral Solution; opium tincture 10 MG (as morphine equivalent) in 1 mL Oral Solution; anhydrous morphine 1 % Oral Solution; anhydrous morphine 10 MG/ML Oral Solution; opium tincture 10 MG (as morphine equivalent) per 1 ML Oral Solution
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)461 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Opium tincture 100 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Opium tincture 100 MG/ML Oral Solution
RxCUI 830196 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Opium
7676IN -
Opium tincture
221134PIN
-
Opium
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Opium Oral Solution
377949SCDF -
Opium tincture Oral Solution
2647814SCDFP -
Opium Oral Liquid Product
1161039SCDG -
Opium Oral Product
1161040SCDG -
Opium tincture Oral Liquid Product
2660094SCDGP -
Opium tincture Oral Product
2660450SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Opium Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Opium tincture 100 MG/ML
830195SCDC
-
Opium tincture 100 MG/ML
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Opium tincture 100 MG/ML
SCDC · 830195 -
Opium Oral Solution
SCDF · 377949 -
Opium tincture Oral Solution
SCDFP · 2647814 -
Opium Oral Liquid Product
SCDG · 1161039 -
Opium Oral Product
SCDG · 1161040 -
Opium tincture Oral Liquid Product
SCDGP · 2660094 -
Opium tincture Oral Product
SCDGP · 2660450
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
5 package NDCs map to RxCUI 830196 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 42799-0217-01 | 118 mL in 1 BOTTLE, PLASTIC (42799-217-01) | Opium Tincture Deodorized | Edenbridge Pharmaceuticals, LLC | 2010-07-15 |
| 42799-0217-02 | 473 mL in 1 BOTTLE, PLASTIC (42799-217-02) | Opium Tincture Deodorized | Edenbridge Pharmaceuticals, LLC | 2010-07-15 |
| 62559-0153-04 | 118 mL in 1 BOTTLE (62559-153-04) | Opium Tincture Deodorized | ANI Pharmaceuticals, Inc. | 2011-02-25 |
| 63629-1965-01 | 118 mL in 1 BOTTLE (63629-1965-1) | Opium Tincture Deodorized | Bryant Ranch Prepack | 2021-02-08 |
| 64950-0258-11 | 118 mL in 1 BOTTLE (64950-258-11) | Opium | Genus Lifesciences Inc. | 2026-05-15 |
Observed labelers:
Edenbridge Pharmaceuticals, LLC (2) ·
ANI Pharmaceuticals, Inc. (1) ·
Bryant Ranch Prepack (1) ·
Genus Lifesciences Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.